#GFAP
Happy #fluorescencefriday lightsheet 🔬 of a cleared 🐁 🧠 showing GFAP labeling for astrocytes. The image inset provides detail of what seem to be the end feet around a vessel. Single cell resolution from a whole 🧠 image by @mind-western.bsky.social @shahrzadbahrampour.bsky.social
November 13, 2026 at 1:21 PM
Four markers, one mouse brain section: NeuN for neurons, MAP2 for dendrites, GFAP for astrocytes and Olig2 for oligodendrocyte lineage. Basically the whole cast in one image 🧠 All from our catalog #Neuroscience #Microscopy
November 13, 2026 at 7:34 PM
Driving APOA1 production in the liver for 2.5 months raised its levels in 5xFAD brains. Astrocyte lipid droplets and GFAP fell, synaptic density rose, plaques shrank in the dentate gyrus, and mice partially recovered performance in a spatial memory test.
November 11, 2026 at 4:53 PM
GFAP can provide insight into neuroinflammation and changes involving the brain's supportive cells. But it's not Alzheimer's-specific. Infections, autoimmune conditions and other causes can also raise it.

Watch -
High GFAP Doesn't Automatically Mean Alzheimer's
GFAP is a brain health biomarker, but it isn't specific to Alzheime...
youtube.com
November 7, 2026 at 6:05 PM
振動マットで全身揺らすと「脳内のゴミ」の洗い流しが促進、ニトロと併用 人体で検証 アルツハイマー予防に期待、Nature系列誌 levtech.jp/media/detail... 29名で実験。血管を広げる薬のニトログリセリンを摂取し振動マットに寝て全身を揺らす→血中のアミロイドβやGFAPが有意に上昇、脳から流れ出た可能性
November 5, 2026 at 11:59 PM
Which immunohistochemical profile is most consistent with this tumor? 

A.Inhibin +, PAX8 +, EMA +, CD10 +
B.Inhibin +, aquaporin-1 +, PAX8 −, EMA −
C.Inhibin +, PAX8 −, EMA +, PR -, SSTR2A -
D.Inhibin −, GFAP +, OLIG2 +, IDH1 R132H +

#NeuroNotes #neuropath #pathology #neuromuscularpath
November 4, 2026 at 4:05 PM
Stage-Specific Roles of Plasma GFAP in Linking Amyloid Cascade in Alzheimer Disease #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.11.03.26366374v1
November 5, 2026 at 2:01 AM
Option C (clear cell/lipidized meningioma) would be EMA, PR and SSTR2A positive and inhibin negative. Option D (clear cell/oligodendroglioma-like diffuse glioma) would be GFAP/OLIG2 positive, often IDH-mutant, and inhibin negative.
November 5, 2026 at 4:00 PM
Immunostains show CD34 labeling (image C), tumor cells positive for GFAP and Olig2 (image D), ATRX is retained, IDH-1 is wild-type (image E), Ki67 proliferation index 5-6 % focally and P53 strong nuclear positivity is <10%. EMA, synaptophysin (image F) and NeuN are negative in tumor cells.
November 5, 2026 at 5:08 PM
Die FDA hat das erste zugelassene Mittel gegen die Alexander-Krankheit genehmigt: Es soll die Produktion des Proteins GFAP bremsen.
FDA lässt erstes Mittel gegen Alexander-Krankheit zu
Die US-Arzneimittelbehörde FDA hat Zanvastro (Zilganersen) am 3. September 2026 zur Behandlung der Alexander-Krankheit bei Kindern und Erwachsenen zugelassen. Die Fachmedien Practical Neurology und NeurologyLive nennen es die erste zugelassene Therap
denkstrom.org
November 4, 2026 at 4:16 PM
#clinical #medicine #Geriatrics interlude- I just saw for the first time ever GFAP and UCHL-1 proteins being ordered for #TBI (traumatic brain injury) in the ED
This is not useful for patients with #dementia. Already have neuronal damage

For sports injuries/concussions in college athletes, fine
Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank - PubMed
These results suggest that peripheral GFAP and NfL are potential biomarkers for the early diagnosis of dementia. In addition, anti-inflammatory therapies in the initial stages of dementia may have pot...
pubmed.ncbi.nlm.nih.gov
November 1, 2026 at 5:05 PM
The fastest way to understand GFAP driven GFP expression in activated mouse Müller glial cells aligning retinal blood.

#gfapdriven #energy #gym #photon #yeet #meta #cellular #frequency #science #metacognition #joedispenza #development
October 30, 2026 at 2:01 PM
October 29th is #WorldStrokeDay 🧠

After ischemic injury, reactive astrocytes ramp up GFAP, a go-to readout for neuroinflammation in stroke models.

Thanks to every neuroscience & cardiovascular researcher working on stroke research 💙

#Neuroscience #NeuroSky
October 29, 2026 at 6:37 PM
📃Scientific paper: Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease

Ref.: Springer, 2022

➡️ Continued on ES/IODE
October 29, 2026 at 12:00 PM
🧠In an MS-related mouse model, [Met5]-enkephalin reduced GFAP-positive astrocyte counts across three regions. In the dentate gyrus.
Low-dose naltrexone showed a different pattern: reductions in the corpus callosum and subventricular zone, but no significant reduction in the dentate gyrus.
#neuron
October 29, 2026 at 6:20 AM
De motie van René Claassen (#GroepMarkuszower) over een validatie- en implementatiestudie naar prehospitale GFAP-sneltesten, is aangenomen. (29247-499) #TweedeKamer

[Volledige tekst]
October 29, 2026 at 9:00 AM
What is the diagnostic proficiency of plasma glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL)?

#DADM research demonstrates plasma GFAP and is elevated in early-onset AD (EOAD) compared to non-dementia

Read More: alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
October 27, 2026 at 5:49 PM
Clinical research published in #TRCI highlights the association between Vitamin D3 and omega-3 supplementation and cognition

Neither vitamin D3 nor omega-3s significantly reduced selected plasma ADRD biomarkers including Aβ and GFAP over 4 years

alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
Effects of long‐term daily supplementation with vitamin D3 and marine omega‐3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trial
INTRODUCTION Vitamin D3 and omega-3 supplementation may slow outcomes related to Alzheimer's disease and related dementias (ADRD), with variation by sex or race, but their effects on ADRD-associated...
alz-journals.onlinelibrary.wiley.com
October 29, 2026 at 5:07 PM
High-sensitivity p-Tau 217 can identify Alzheimer's-related pathology in pre-symptomatic and early symptomatic individuals. When evaluated alongside NfL and GFAP, you get an accurate view of what is happening in the brain. https://www.apollohealthco.com/early-detection-the-advantages-of-p-tau-217/
October 28, 2026 at 4:15 PM
Anemia is associated with 66% increased risk of dementia and increases in p-tau 217, Nfl, and GFAP blood biomarkers for Alzheimer's risk www.medscape.com/viewarticle/...
Anemia Linked to Alzheimer’s Biomarkers, Dementia Risk
Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood biomarkers at highest risk.
www.medscape.com
October 26, 2026 at 3:14 PM
The authors included RRIDs in their in Molecular Therapy paper! RRIDs improve reproducibility in scientific research. #methodsmatter #reproducibility #accelerateopenscience
Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander disease
Read the full paper: Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander disease
doi.org
October 24, 2026 at 7:00 AM
Blood levels of the protein GFAP may help flag brain injuries missed by CT scans, distinguishing acute injury from no imaging evidence of damage within 24 hours of trauma. doi.org/hcpkkx
Blood test can help clinicians better identify brain injury severity in patients
Clinician-scientists hope to expand the use of blood-based biomarker tests for traumatic brain injury (TBI) to improve identification and escalation of care for patients whose diagnosis otherwise might be missed.
medicalxpress.com
October 23, 2026 at 4:01 AM
$OCS Latest company news, Oct 22, 2026: new ACUITY biomarker data in optic neuritis, with NfL stable and GFAP below baseline on privosegtor through month 6.

https://www.merlintrader.com/oculis-holding-ag-stock-hub/
Oculis Holding AG $OCS: Pipeline, Cash And Clinical Tests
Oculis research on privosegtor, licaminlimab and the DIAMOND setback, with trial endpoints, financial resources, dilution and regulatory risks.
www.merlintrader.com
October 22, 2026 at 8:03 PM
Look into 'Joy's' diagnosis, semicircular canal dehiscence/Minor's syndrome. It has nothing whatsoever to do with microwaves or DEW attacks:
en.wikipedia.org/wiki/Superio...
As for the biomarkers NfL and GFAP, they also don't signify a DEW attack. Why pretend that they do?
bsky.app/profile/dann...
October 20, 2026 at 7:55 PM